APTA — Aptahem AB Share News
0.000.00%
Last trade - 00:00- SEK8.32m
- SEK6.60m
Brief: Aptahem Receives Patent Approval In India For Patent Family 1
Brief: Aptahem Rights Issue Oversubscribed
Brief: Aptahem Enters Agreement With Granzer Regulatory Consulting
Brief: Aptahem Largest Shareholder Suggests Dr Bert Junno New Chairman
Brief: Aptahem AB - Intends To Carry Out Rights Issue Of Units Of About Sek 32.3 mln
Brief: Aptahem Chairman Announces Resignation
Brief: Aptahem Q2 Pretax Loss Narrows To SEK 3.9 Million
Brief: Aptahem Enters A Collaboration With University Health Network In Canada To Test Apta-1 In A Coronavirus Model
Brief: Aptahem's Collaboration With Örebro University Further Increases Understanding Of Apta-1
Brief: Aptahem Q1 Pretax Loss Narrows To SEK 3 Million
Brief: Aptahem Q4 Pretax Loss Narrows To SEK 3.6 Million
Brief: Recipharm Partners With Aptahem For Formulation Of Apta-1 Drug Candidate
Brief: Aptahem Enters Consortium With Örebro University, AnaMar And Dalhousie University
Brief: Aptahem Enters Agreement With Recipharm
Brief: Aptahem Q3 Pretax Loss Widens To SEK 5.5 Million
Brief: Aptahem: Strengthened Results With Apta-1 From Completed NHP Study
Brief: Aptahem Signs Agreement With New Contract Manufacturer
Brief: Aptahem Reports Positive Results Of Apta-1 Study
Brief: Aptahem Reports Delay In Delivery Of Its Drug Product